Researchers at ASH shared Phase III data comparing the pre- and five-year post-treatment adjusted annualized bleeding rates, ...

Data presented at ASH suggest that the CRISPR therapy could provide a one-time functional cure in children as young as 5 ...

Of the 11 patients treated with BE-CAR7 T cells, seven are in remission, including one patient who has been in remission for three years.

Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely enables them to hide from immune attack.

The firm said it is planning a regulatory filing with the European Medicines Agency next year to begin clinical studies of PCT1:CO-STIM.

As part of the trial, investigators will initially evaluate ARO-MAPT in up to 64 healthy subjects, followed by up to 48 Alzheimer's disease patients.

Data presented at ASH suggested that CDK4/6 inhibitors given with chemo for Rb-deficient tumors could mitigate the risk of secondary myeloid neoplasms.